CD274 and melanoma: In melanoma-bearing mice, the combination of oral Bifidobacterium (containing Bifidobacterium breve and Bifidobacterium longum) with PD-L1 inhibitors reduced tumor size by 80%, whereas PD-L1 inhibitors alone achieved only a 40% reduction (18).